Biggest changeEarnings per share reconciliation to adjusted earnings per share (shares in thousands): Year Ended June 30, 2023 2022 2021 Earnings per share, diluted (GAAP) $ 2.05 $ 6.43 $ 1.36 Effect on diluted earnings per share: Deferred revenue adjustment - 0.18 - CEO transition costs - 0.13 - Restructuring expense 0.41 0.53 0.13 Business acquisition and integration expense 0.94 1.09 0.61 Intangible amortization expense 1.34 1.99 - Gain on sale of assets (0.29) - - Pre-acquisition interest expense, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, and investment impairment 0.42 1.00 0.52 Net tax benefit related to a valuation allowance release (0.14) - - Income tax impact on non-GAAP adjustments (1) (0.70) (1.06) (0.32) Net loss (income) from discontinued operations attributable to Adtalem 0.18 (7.17) (0.13) Adjusted earnings per share, diluted (non-GAAP) $ 4.21 $ 3.11 $ 2.18 Diluted shares used in non-GAAP EPS calculation 45,600 48,804 51,645 (1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements. 74 Table of Contents Reconciliation to adjusted EBITDA (in thousands): Year Ended June 30, Increase/(Decrease) 2023 2022 $ % Chamberlain: Operating income (GAAP) $ 134,685 $ 124,414 $ 10,271 8.3 % Restructuring expense 818 2,838 (2,020) Depreciation 17,264 18,547 (1,283) Stock-based compensation 4,719 6,707 (1,988) Adjusted EBITDA (non-GAAP) $ 157,486 $ 152,506 $ 4,980 3.3 % Adjusted EBITDA margin (non-GAAP) 27.6 % 27.4 % Walden: Operating income (loss) (GAAP) $ 35,880 $ (5,306) $ 41,186 NM Deferred revenue adjustment — 8,561 (8,561) Restructuring expense 3,245 4,053 (808) Intangible amortization expense 61,239 97,274 (36,035) Litigation reserve 10,000 — 10,000 Depreciation 9,492 9,255 237 Stock-based compensation 3,861 3,029 832 Adjusted EBITDA (non-GAAP) $ 123,717 $ 116,866 $ 6,851 5.9 % Adjusted EBITDA margin (non-GAAP) 23.2 % 24.1 % Medical and Veterinary: Operating income (GAAP) $ 59,649 $ 59,357 $ 292 0.5 % Restructuring expense 7,687 9,791 (2,104) Depreciation 12,475 13,890 (1,415) Stock-based compensation 3,003 3,896 (893) Adjusted EBITDA (non-GAAP) $ 82,814 $ 86,934 $ (4,120) (4.7) % Adjusted EBITDA margin (non-GAAP) 23.9 % 25.7 % Home Office and Other: Operating loss (GAAP) $ (62,044) $ (101,719) $ 39,675 39.0 % CEO transition costs — 6,195 (6,195) Restructuring expense 7,067 8,946 (1,879) Business acquisition and integration expense 42,661 53,198 (10,537) Gain on sale of assets (13,317) — (13,317) Depreciation 2,344 2,882 (538) Stock-based compensation 2,716 2,784 (68) Adjusted EBITDA (non-GAAP) $ (20,573) $ (27,714) $ 7,141 25.8 % Adtalem Global Education: Net income attributable to Adtalem (GAAP) $ 93,358 $ 310,991 $ (217,633) (70.0) % Net loss (income) from discontinued operations attributable to Adtalem 8,394 (346,946) 355,340 Interest expense 63,100 129,348 (66,248) Other income, net (6,965) (1,108) (5,857) Provision for (benefit from) income taxes 10,283 (15,539) 25,822 Operating income (GAAP) 168,170 76,746 91,424 Depreciation and amortization 102,814 141,848 (39,034) Stock-based compensation 14,299 16,416 (2,117) Deferred revenue adjustment — 8,561 (8,561) CEO transition costs — 6,195 (6,195) Restructuring expense 18,817 25,628 (6,811) Business acquisition and integration expense 42,661 53,198 (10,537) Litigation reserve 10,000 — 10,000 Gain on sale of assets (13,317) — (13,317) Adjusted EBITDA (non-GAAP) $ 343,444 $ 328,592 $ 14,852 4.5 % Adjusted EBITDA margin (non-GAAP) 23.7 % 23.8 % 75 Table of Contents Year Ended June 30, Increase/(Decrease) 2022 2021 $ % Chamberlain: Operating income (GAAP) $ 124,414 $ 128,851 $ (4,437) (3.4) % Restructuring expense 2,838 — 2,838 Depreciation 18,547 16,123 2,424 Stock-based compensation 6,707 5,181 1,526 Adjusted EBITDA (non-GAAP) $ 152,506 $ 150,155 $ 2,351 1.6 % Adjusted EBITDA margin (non-GAAP) 27.4 % 26.6 % Walden: Operating loss (GAAP) $ (5,306) $ — $ (5,306) NM Deferred revenue adjustment 8,561 — 8,561 Restructuring expense 4,053 — 4,053 Intangible amortization expense 97,274 — 97,274 Depreciation 9,255 — 9,255 Stock-based compensation 3,029 — 3,029 Adjusted EBITDA (non-GAAP) $ 116,866 $ — $ 116,866 NM Adjusted EBITDA margin (non-GAAP) 24.1 % N/A Medical and Veterinary: Operating income (GAAP) $ 59,357 $ 60,199 $ (842) (1.4) % Restructuring expense 9,791 — 9,791 Depreciation 13,890 14,431 (541) Stock-based compensation 3,896 3,321 575 Adjusted EBITDA (non-GAAP) $ 86,934 $ 77,951 $ 8,983 11.5 % Adjusted EBITDA margin (non-GAAP) 25.7 % 23.2 % Home Office and Other: Operating loss (GAAP) $ (101,719) $ (78,651) $ (23,068) (29.3) % CEO transition costs 6,195 — 6,195 Restructuring expense 8,946 6,869 2,077 Business acquisition and integration expense 53,198 31,593 21,605 Depreciation 2,882 3,334 (452) Stock-based compensation 2,784 4,322 (1,538) Adjusted EBITDA (non-GAAP) $ (27,714) $ (32,533) $ 4,819 14.8 % Adtalem Global Education: Net income attributable to Adtalem (GAAP) $ 310,991 $ 70,027 $ 240,964 344.1 % Net income from discontinued operations attributable to Adtalem (346,946) (6,579) (340,367) Interest expense 129,348 41,365 87,983 Other income, net (1,108) (6,732) 5,624 (Benefit from) provision for income taxes (15,539) 12,318 (27,857) Operating income (GAAP) 76,746 110,399 (33,653) Depreciation and amortization 141,848 33,888 107,960 Stock-based compensation 16,416 12,824 3,592 Deferred revenue adjustment 8,561 — 8,561 CEO transition costs 6,195 — 6,195 Restructuring expense 25,628 6,869 18,759 Business acquisition and integration expense 53,198 31,593 21,605 Adjusted EBITDA (non-GAAP) $ 328,592 $ 195,573 $ 133,019 68.0 % Adjusted EBITDA margin (non-GAAP) 23.8 % 21.7 %
Biggest changeDiluted earnings per share reconciliation to adjusted earnings per share (shares in thousands): Year Ended June 30, 2024 2023 Diluted earnings per share (GAAP) $ 3.39 $ 2.05 Effect on diluted earnings per share: Restructuring expense 0.05 0.41 Business acquisition and integration expense 0.85 0.94 Amortization of acquired intangible assets 0.88 1.34 Gain on sale of assets - (0.29) Write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, loss on assets held for sale, and debt modification costs 0.52 0.42 Tax benefit due to change in valuation allowance - (0.14) Tax benefit due to change in unrecognized tax benefits (0.14) - Income tax impact on non-GAAP adjustments (1) (0.57) (0.70) Loss from discontinued operations 0.02 0.18 Adjusted earnings per share (non-GAAP) $ 5.01 $ 4.21 Diluted shares used in non-GAAP EPS calculation 40,307 45,600 (1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements. 51 Table of Contents Reconciliation to adjusted EBITDA (in thousands): Year Ended June 30, Increase/(Decrease) 2024 2023 $ % Chamberlain: Operating income (GAAP) $ 137,800 $ 134,685 $ 3,115 2.3 % Restructuring expense — 818 (818) Depreciation 18,752 17,175 1,577 Amortization of cloud computing implementation assets 1,332 89 1,243 Stock-based compensation 8,303 4,719 3,584 Adjusted EBITDA (non-GAAP) $ 166,187 $ 157,486 $ 8,701 5.5 % Adjusted EBITDA margin (non-GAAP) 26.2 % 27.6 % Walden: Operating income (GAAP) $ 77,179 $ 35,880 $ 41,299 115.1 % Restructuring expense (776) 3,245 (4,021) Amortization of acquired intangible assets 35,644 61,239 (25,595) Litigation reserve 18,500 10,000 8,500 Depreciation 7,389 9,419 (2,030) Amortization of cloud computing implementation assets 1,331 73 1,258 Stock-based compensation 7,525 3,861 3,664 Adjusted EBITDA (non-GAAP) $ 146,792 $ 123,717 $ 23,075 18.7 % Adjusted EBITDA margin (non-GAAP) 24.7 % 23.2 % Medical and Veterinary: Operating income (GAAP) $ 71,065 $ 59,649 $ 11,416 19.1 % Restructuring expense 442 7,687 (7,245) Depreciation 11,983 12,438 (455) Amortization of cloud computing implementation assets 469 37 432 Stock-based compensation 4,930 3,003 1,927 Adjusted EBITDA (non-GAAP) $ 88,889 $ 82,814 $ 6,075 7.3 % Adjusted EBITDA margin (non-GAAP) 25.0 % 23.9 % Home Office: Operating loss (GAAP) $ (68,990) $ (62,044) $ (6,946) (11.2) % Restructuring expense 2,204 7,067 (4,863) Business acquisition and integration expense 34,215 42,661 (8,446) Loss on assets held for sale 647 — 647 Debt modification costs 848 — 848 Gain on sale of assets — (13,317) 13,317 Depreciation 1,552 2,344 (792) Stock-based compensation 5,189 2,716 2,473 Adjusted EBITDA (non-GAAP) $ (24,335) $ (20,573) $ (3,762) (18.3) % Adtalem Global Education: Net income (GAAP) $ 136,777 $ 93,358 $ 43,419 46.5 % Loss from discontinued operations 936 8,394 (7,458) Interest expense 63,659 63,100 559 Other income, net (10,542) (6,965) (3,577) Provision for income taxes 26,224 10,283 15,941 Operating income (GAAP) 217,054 168,170 48,884 Depreciation and amortization 78,452 102,814 (24,362) Stock-based compensation 25,947 14,299 11,648 Restructuring expense 1,870 18,817 (16,947) Business acquisition and integration expense 34,215 42,661 (8,446) Litigation reserve 18,500 10,000 8,500 Loss on assets held for sale 647 — 647 Debt modification costs 848 — 848 Gain on sale of assets — (13,317) 13,317 Adjusted EBITDA (non-GAAP) $ 377,533 $ 343,444 $ 34,089 9.9 % Adjusted EBITDA margin (non-GAAP) 23.8 % 23.7 % 52 Table of Contents